Chronic Cannabis Use in the Compassionate Investigational New Drug Program: An Examination of Benefits and Adverse Effects of Legal Clinical Cannabis

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Unknown venue

• Publication date

  2002-02-13

• Fields of study

  Law, Medicine, Psychology

• Identifiers
  DOI 10.1300/J175V02N01_02
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tetrahydrocannabinol content and differences in marijuana smoking behavior

  2004cited by this paper
• Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential

  2002cited by this paper
• Marijuana and Cannabinoids

  2001cited by this paper
• Effects of Smoked Marijuana on the Lung and Its Immune Defenses

  2001cited by this paper
• Prospects for New Cannabis-Based Prescription Medicines

  2001influential reference
• P300 amplitude as a possible correlate of frontal degeneration in schizophrenia.

  2001cited by this paper
• Cannabis “Vaporization”: A Promising Strategy for Smoke Harm Reduction

  2001cited by this paper
• Harm Reduction Associated with Inhalation and Oral Administration of Cannabis and THC

  2001cited by this paper
• Effects of frequent marijuana use on brain tissue volume and composition

  2000cited by this paper
• The effect of motivational instructions on P300 amplitude.

  2000cited by this paper
• The P300 brain potential is reduced in smokers

  2000cited by this paper
• DIURNAL VARIATION IN THE P300 COMPONENT OF HUMAN COGNITIVE EVENT-RELATED POTENTIAL

  2000cited by this paper
• Cannabis use and cognitive decline in persons under 65 years of age.

  1999cited by this paper
• Marijuana use and increased risk of squamous cell carcinoma of the head and neck.

  1999cited by this paper
• Cannabis and Cognitive Functioning: Author's acknowledgements

  1998cited by this paper
• Marijuana Myths, Marijuana Facts: A Review of the Scientific Evidence

  1998cited by this paper
• Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.

  1998cited by this paper
• Marijuana, immunity and infection.

  1998cited by this paper
• Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age.

  1997cited by this paper
• The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.

  1997cited by this paper
• Are choice and self-administration of marijuana related to delta 9-THC content?

  1997cited by this paper
• Marijuana use and mortality.

  1997cited by this paper
• Cognitive correlates of long-term cannabis use in Costa Rican men.

  1996cited by this paper
• The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study.

  1996cited by this paper
• Spehlmann's evoked potential primer: visual, auditory, and somatosensory evoked potentials in clinical diagnosis

  1995cited by this paper
• Auditory and visual P300 event related potentials are not altered in medically and psychiatrically normal chronic marihuana users.

  1995cited by this paper
• Preference for high- versus low-potency marijuana.

  1994cited by this paper
• Spehlmann's evoked potential primer : visual, auditory, and somatosensory evoked potentials in clinical diagnosis.

  1994cited by this paper
• Health care use by frequent marijuana smokers who do not smoke tobacco.

  1993cited by this paper
• Marijuana and immunity.

  1992cited by this paper
• Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women.

  1991cited by this paper
• Marijuana & AIDS : pot, politics & PWAs in America

  1991cited by this paper
• Respiratory effects of non-tobacco cigarettes: a longitudinal study in general population.

  1991cited by this paper
• Some physical characteristics of NIDA marijuana cigarettes.

  1989influential reference
• No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study.

  1989cited by this paper
• Bronchial pathology in chronic marijuana smokers: a light and electron microscopic study.

  1988cited by this paper
• Marihuana smoking suppresses luteinizing hormone in women.

  1986cited by this paper
• Acute effects of marihuana on luteinizing hormone in menopausal women

  1986cited by this paper
• Evoked potential primer: Visual, auditory, and somatosensory evoked potentials in clinical diagnosis

  1985cited by this paper
• Neurological and neuroradiological examination of chronic cannabis smokers

  1983cited by this paper
• Cannabis in Costa Rica : a study of chronic marihuana use

  1980influential reference
• Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels.

  1978cited by this paper
• Computed tomographic examination of heavy marijuana smokers.

  1977cited by this paper
• Absence of cerebral atrophy in chronic cannabis users. Evaluation by computerized transaxial tomography.

  1977cited by this paper
• Gynecomastia and cannabis smoking. A nonassociation among US Army soldiers.

  1977cited by this paper
• Hashish: Studies of Long-Term Use

  1977cited by this paper
• Ganja in Jamaica: A Medical Anthropological Study of Chronic Marihuana Use

  1976influential reference
• Marijuana and Health Hazards: Methodological Issues in Current Research

  1976cited by this paper
• THE 94‐DAY CANNABIS STUDY

  1976influential reference
• Effects of Cannabis in Another Culture. (Book Reviews: Ganja in Jamaica. A Medical Anthropological Study of Chronic Marihuana Use)

  1975influential reference
• Chapter 14 – Marijuana and Brain Dysfunction: Selected Research Issues

  1975cited by this paper
• Inhibition of Cellular Mediated Immunity in Marihuana Smokers

  1974cited by this paper
• Depression of plasma testosterone levels after chronic intensive marihuana use.

  1974cited by this paper
• Report of the Indian Hemp Drugs Commission, 1893-94: a critical review.

  1972cited by this paper
• Gynecomastia in marihuana users.

  1972cited by this paper
• Cerebral atrophy in young cannabis smokers.

  1971cited by this paper
• Marihuana smoking and intraocular pressure.

  1971cited by this paper
• PRACTICAL HINTS

  1902cited by this paper

• Optimal gamma-ray doses for inducing mutation in cannabis sativa L. cultivars at different growth stages

  2025cites this paper
• Effect of Gamma Irradiation on Cannabinoid, Terpene, and Moisture Content of Cannabis Biomass

  2023cites this paper
• The Fallacy of a One Size Fits All Cannabis Policy

  2022cites this paper
• The Risks and Benefits of Cannabis in the Dermatology Clinic

  2018cites this paper
• Essays on Regulating Pain and Pleasure

  2018cites this paper
• Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.

  2018cites this paper
• Practical considerations in medical cannabis administration and dosing.

  2018cites this paper
• Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions.

  2018cites this paper
• Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.

  2018cites this paper
• Cannabis and epilepsy: An ancient treatment returns to the fore.

  2017cites this paper
• Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment.

  2016cites this paper
• Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues

  2016cites this paper
• Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States

  2016cites this paper
• Medical marijuana research

  2016cites this paper
• Cannabinoids for the Treatment of Movement Disorders

  2015cites this paper
• Cannabinoids in the management of dif cult to treat pain

  2014cites this paper
• Medicinal Marijuana: A Critical Review of Selected Literature

  2014cites this paper
• Medical marijuana in neurology

  2014cites this paper
• Drugs of Abuse and Immuno-Modulation

  2013cites this paper
• Spectral differentiation of Cannabis sativa L from maize using hyperspectral indices.

  2013cites this paper
• Role of Cannabinoids in Pain Management

  2013cites this paper
• Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized-controlled Trial Results

  2013cites this paper
• Meyler’s Side Effects of Herbal Medicines

  2012cites this paper
• [Docket No. DEA–352N] Denial of Petition To Initiate Proceedings To Reschedule Marijuana AGENCY: Drug Enforcement

  2011cites this paper
• Cannabis - Philosophy for Everyone: What Were We Just Talking About?

  2010cites this paper
• The Medicalization of Cannabis

  2010cites this paper
• Phytocannabinoids and endocannabinoids.

  2009cites this paper
• Adverse effects of medical cannabinoids: a systematic review

  2008cites this paper
• Cannabinoids in the management of difficult to treat pain

  2008cites this paper
• Regulating compassion: an overview of Canada's federal medical cannabis policy and practice

  2008cites this paper
• The medical geography of cannabinoid botanicals in Washington State: Access, delivery, and distress

  2008cites this paper
• MEDICAL MARIJUANA: REDEFINING THE SOCIAL POLITICS OF REALITY

  2008cites this paper
• A practical guide for clinicians

  2007cites this paper
• The Toxicology of Cannabis and Cannabis Prohibition

  2007cites this paper
• Dosing medical marijuana: rational guidelines on trial in Washington State.

  2007cites this paper
• Mother's Milk and the Muffin Man

  2006cites this paper
• The Legal Status of Medical Marijuana

  2006cites this paper
• The Solution to the Medicinal Cannabis Problem

  2006cites this paper
• Neuropsychiatry: Schizophrenia, Depression, and Anxiety

  2005cites this paper
• Harm reduction-the cannabis paradox

  2005cites this paper
• Pharmacology of cannabinoids.

  2004cites this paper
• The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans

  2004cites this paper
• Clinical Pharmacodynamics of Cannabinoids

  2004cites this paper
• Introduction: Cannabis: From Pariah to Prescription

  2004cites this paper
• Ptosis in patients with hemispheric strokes

  2003cites this paper
• Restoration of chronic‐ Δ9‐THC‐induced decline in sexuality in male rats by a novel benzoflavone moiety from Passiflora incarnata Linn

  2003cites this paper
• Treatment of Tourette ’ s syndrome with ∆ 9-tetrahydrocannabinol : results from clinical trials

  2003cites this paper
• Cannabis is more than simply Δ9-tetrahydrocannabinol

  2003cites this paper
• Clinical Pharmacokinetics of Cannabinoids

  2003cites this paper
• Cannabis series ‐ the whole story Part 6: Potential risks related to acute and chronic use of cannabis

  2003cites this paper
• Cannabinoids reduce symptoms of Tourette’s syndrome

  2003cites this paper
• Pharmacokinetics and Pharmacodynamics of Cannabinoids

  2003cites this paper
• Cannabis and Harm Reduction: A Nursing Perspective

  2002cites this paper
• Cannabis Treatments in Obstetrics and Gynecology: A Historical Review

  2002cites this paper
• findings of a longitudinal study of effects

  year unknowncites this paper
• CANNABIS AN UPDATE 1999-2002

  year unknowncites this paper